Ontario study reheats rosiglitazone controversyResearch recommends avoiding the medication due to cardiovascular risks Dabigatran vs. warfarin in atrial fibrillation Optimal dose of ASA Prolonged PR interval has long-term risk A new approach to heart attacks Quick angioplasty improves outcomes - study CARDIOLOGY: Big men are at greater risk for atrial fibrillation CARDIOLOGY: The pre-operative heart check Identifying existing risks, conducting proper exams and aiding risk reduction are key components of cardiac evaluation for noncardiac surgery CARDIOLOGY: Highlights from the ACC Key late-breaking clinical trials from the American College of Cardiology’s 58th annual scientific session CARDIOLOGY: Taming atrial fibrillation As a growing number of new cases contribute to the ballooning costs of health care, new surgical approaches and genetic targets can help keep this condition under control CARDIOLOGY: Syncope a risk for sudden death in hypertrophic cardiomyopathy First Previous 83 84 85 86 87 Next Last
